Device handling study of a novel breath-actuated inhaler Synchrobreathe vs pMDI
S. Balamurugan (Chennai, India), K. Apte (Pune, India), B. Singh (Lucknow, India), A. Deb (Varanasi, India), C. Deshmukh (Mumbai, India), K. Modi (Mumbai, India), A. Godse (Mumbai, India), R. Dhar (Kolkata, India), K. Lahiri (Mumbai , India), V. Singh (Mumbai , India), H. Pandya (Ahmedabad, India), S. Rajan (Mumbai , India), A. Vaidya (Mumbai, India), V. Gaur (Mumbai, India), J. Gogtay (Mumbai, India)
Source: International Congress 2019 – COPD treatment: clinical trials, cohorts and inhaler device studies
Disease area: Airway diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Balamurugan (Chennai, India), K. Apte (Pune, India), B. Singh (Lucknow, India), A. Deb (Varanasi, India), C. Deshmukh (Mumbai, India), K. Modi (Mumbai, India), A. Godse (Mumbai, India), R. Dhar (Kolkata, India), K. Lahiri (Mumbai , India), V. Singh (Mumbai , India), H. Pandya (Ahmedabad, India), S. Rajan (Mumbai , India), A. Vaidya (Mumbai, India), V. Gaur (Mumbai, India), J. Gogtay (Mumbai, India). Device handling study of a novel breath-actuated inhaler Synchrobreathe vs pMDI. 4223
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Critical handling errors with dry-powder, metered dose and soft-mist inhaler devices in an observational COPD study Source: International Congress 2019 – COPD treatment: clinical trials, cohorts and inhaler device studies Year: 2019
Comparison of proficiency of pressurized metered dose inhaler (pMDI) use with asthma control Source: Annual Congress 2008 - Recent advances in the treatment and pathogenesis of asthma Year: 2008
Assessment of relative potency of salbutamol administered via a metered-dose inhaler plus spacer or via a dry-powder inhaler in asthma patients Source: Eur Respir J 2006; 28: Suppl. 50, 209s Year: 2006
Technique training doesn‘t improve patients ability to use pressurised metered dose inhalers (pMDIs) Source: Annual Congress 2009 - Quality of treatment in primary respiratory care Year: 2009
Assessment of the suitability of filters for use in clinical studies with an HFA fluticasone propionate pressurized metered dose inhaler (pMDI) and a valved holding chamber (VHC) Source: Annual Congress 2011 - Lung function today and tomorrow II Year: 2011
Preference for novel soft mist inhaler over pMDI in patients with COPD Source: Eur Respir J 2004; 24: Suppl. 48, 88s Year: 2004
Bronchodilator response to salbutamol administered through metered-dose inhaler plus spacer or dry-powder inhaler in asthmatic patients Source: Eur Respir J 2001; 18: Suppl. 33, 101s Year: 2001
In vitro comparison of aerosol characteristics of HFA albuterol (salbutamol) pressurized metered dose inhaler (pMDI) formulation from three valved holding chambers (VHCs) Source: Annual Congress 2011 - Drug delivery and pharmacokinetics II Year: 2011
In vitro evaluation of spacers in comparison with T-adapters in mechanical ventilation with pressurized metered dose inhalers (pMDI) and vibrating mesh nebulizer. Source: International Congress 2019 – COPD and other specific entities in intensive care unit medicine Year: 2019
Efficacy and safety of salbutamol delivered via a novel multidose dry powder inhaler in comparison with two conventional dry powder inhalers and a pMDI in asthmatic subjects Source: Eur Respir J 2001; 18: Suppl. 33, 50s Year: 2001
The effect of Clip-tone® and its smartphone application on optimization of metered-dose inhaler inhalation technique Source: Virtual Congress 2020 – How to overcome deficiencies in skills in bedside training by virtual tools and simulation- where do we go? Year: 2020
Asthma control with a breath-actuated pressurised metered dose inhaler (BAI) and prevalence of oral candidiasis: a prescribing claims study of 1701 patients prescribed a traditional pressurised metered dose inhaler (MDI) plus spacer or a BAI Source: Eur Respir J 2002; 20: Suppl. 38, 78s Year: 2002
Effect of switching from salmeterol/fluticasone dry powder inhaler to formoterol/fluticasone pressurized metered-dose inhaler in elderly asthma patients Source: International Congress 2016 – Asthma management Year: 2016
In vitro comparison of aerosol characteristics of HFA ipratropium bromide pressurized metered dose inhaler (pMDI) formulation from three valved holding chambers (VHCs) Source: Annual Congress 2011 - Drug delivery and pharmacokinetics I Year: 2011
Impact of inhalation delay on medication delivery from a salbutamol HFA pressurized metered dose inhaler used with and without a new prototype portable valved holding chamber Source: International Congress 2019 – COPD treatment: clinical trials, cohorts and inhaler device studies Year: 2019
Technique: the usual problem of metered dose inhalers Source: Eur Respir J 2002; 20: Suppl. 38, 503s Year: 2002
Pharmaceutical development of salmeterol HFA metered dose inhaler Source: Eur Respir J 2004; 24: Suppl. 48, 582s Year: 2004
Comparison of a dry powder inhaler (DPI) to a pressurized metered-dose inhaler (pMDI) formulation of extra fine beclomethasone dipropionate/formoterol fumarate/glycopyrronium bromide (BDP/FF/GB) in patients with COPD: The TRI-D study. Source: Virtual Congress 2020 – COPD : inhaled corticosteroids, bronchodilators and eosinophils Year: 2020
Improvement in the drug delivery of salmeterol/fluticasone via a novel breath actuatedpressurized metered dose inhaler with a dose counter Source: International Congress 2019 – COPD treatment: clinical trials, cohorts and inhaler device studies Year: 2019
Efficacy and safety of new formulation of fluticasone propionate/salmeterol delivered via a HFA pMDI inhaler in patients with asthma Source: Virtual Congress 2020 – Asthma inhalers: devices and adherence studies Year: 2020